Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A07983 | 32290535 | Nutrients | Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases. | 2020 | Details |
A07984 | 32290381 | Int J Environ Res Public Health | Sex Hormone-Dependent Physiology and Diseases of Liver. | 2020 | Details |
A07985 | 32289885 | Cell Biochem Funct | Retinoic acid induced 16 deficiency exacerbates high-fat diet-induced steatohepatitis in mice. | 2020 | Details |
A07986 | 32289535 | Clin Gastroenterol Hepatol | Cost Effectiveness of Different Strategies for Detecting Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Based on United States Health Care System. | 2020 | Details |
A07987 | 32289432 | Life Sci | High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling. | 2020 | Details |
A07988 | 32289180 | Eur J Clin Invest | Prevalence and risk factors of fatty liver in Portuguese adults. | 2020 | Details |
A07989 | 32289115 | JHEP Rep | Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. | 2020 | Details |
A07990 | 32287173 | Am J Case Rep | Hepatic Artery Thrombosis and Takotsubo Syndrome After Liver Transplantation - Which Came First? | 2020 | Details |
A07991 | 32286882 | Am J Physiol Endocrinol Metab | HDL-apoA-I kinetics in response to 16 wk of exercise training in men with nonalcoholic fatty liver disease. | 2020 | Details |
A07992 | 32285823 | Wiad Lek | Changes in the level of α1-antitrypsin in patients with non-alcoholic fatty liver disease. | 2020 | Details |
A07993 | 32285676 | J Med Chem | Design, Synthesis, and Biological Evaluation of New Peripheral 5HT2A Antagonists for Nonalcoholic Fatty Liver Disease. | 2020 | Details |
A07994 | 32285340 | Adv Ther | Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review. | 2020 | Details |
A07995 | 32284169 | Biochem Biophys Res Commun | Effect of methionine/choline-deficient diet and high-fat diet-induced steatohepatitis on mitochondrial homeostasis in mice. | 2020 | Details |
A07996 | 32284046 | Lipids Health Dis | Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease. | 2020 | Details |
A07997 | 32284043 | Lipids Health Dis | Orotic acid-treated hepatocellular carcinoma cells resist steatosis by modification of fatty acid metabolism. | 2020 | Details |
A07999 | 32283679 | J Clin Med | Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) Is Independently Associated with Cardiovascular Risk in a Large Austrian Screening Cohort. | 2020 | Details |
A08000 | 32283406 | Environ Pollut | Long-term bisphenol S exposure aggravates non-alcoholic fatty liver by regulating lipid metabolism and inducing endoplasmic reticulum stress response with activation of unfolded protein response in male zebrafish. | 2020 | Details |
A08001 | 32283200 | Food Chem Toxicol | Impaired ferritinophagy flux induced by high fat diet mediates hepatic insulin resistance via endoplasmic reticulum stress. | 2020 | Details |
A08002 | 32283070 | Chem Biol Interact | Role of epidermal growth factor receptor in liver injury and lipid metabolism: Emerging new roles for an old receptor. | 2020 | Details |
A08003 | 32282335 | Am J Gastroenterol | Light-to-Moderate Alcohol Consumption Is Associated With Increased Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease: A Nine-Year Cohort Study. | 2020 | Details |
A08004 | 32282030 | Br Med Bull | Obeticholic acid-a new therapy in PBC and NASH. | 2020 | Details |
A08005 | 32281943 | JMIR Mhealth Uhealth | Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial. | 2020 | Details |
A08006 | 32281563 | J Oleo Sci | Epigallocatechin Gallate Suppresses Inflammatory Responses by Inhibiting Toll-like Receptor 4 Signaling and Alleviates Insulin Resistance in the Livers of High-fat-diet Rats. | 2020 | Details |
A08007 | 32281324 | Korean Circ J | A Close Relationship between Non-Alcoholic Fatty Liver Disease Marker and New-Onset Hypertension in Healthy Korean Adults. | 2020 | Details |
A08008 | 32281248 | Liver Int | Impact of osteopontin on the development of non-alcoholic liver disease and related hepatocellular carcinoma. | 2020 | Details |
A08009 | 32280969 | Clin Infect Dis | Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus. | 2020 | Details |
A08010 | 32280772 | JGH Open | Screening for non-alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter-transient elastography. | 2019 | Details |
A08011 | 32280744 | Tomography | Relationship Between Urolithiasis and Fatty Liver Disease: Findings in Computed Tomography. | 2020 | Details |
A08012 | 32280468 | Gastroenterol Rep (Oxf) | Radiomics based on artificial intelligence in liver diseases: where we are? | 2020 | Details |
A08013 | 32280452 | Cell Biosci | Nonalcoholic fatty liver disease experiences accumulation of hepatic liquid crystal associated with increasing lipophagy. | 2020 | Details |
A08014 | 32280349 | Case Rep Med | Clinical Case Series of Decrease in Shear Wave Elastography Values in Ten Diabetic Dyslipidemia Patients Having NAFLD with Saroglitazar 4 mg: An Indian Experience. | 2020 | Details |
A08015 | 32280254 | Diabetes Metab Syndr Obes | Low-Magnitude High-Frequency Vibration Decreases Body Weight Gain and Increases Muscle Strength by Enhancing the p38 and AMPK Pathways in db/db Mice. | 2020 | Details |
A08017 | 32279997 | Biochem Biophys Res Commun | Potential use of C-phycocyanin in non-alcoholic fatty liver disease. | 2020 | Details |
A08018 | 32279995 | Biochem Biophys Res Commun | LASS2 regulates hepatocyte steatosis by interacting with NDUFS2/OXPHOS related proteins. | 2020 | Details |
A08019 | 32279432 | Liver Int | Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation. | 2020 | Details |
A08020 | 32279410 | J Anim Physiol Anim Nutr (Berl) | Campomanesia sp. flour attenuates non-alcoholic fatty liver disease on rats fed with a hypercaloric diet. | 2020 | Details |
A08021 | 32279091 | Mamm Genome | Epigenetic contribution to obesity. | 2020 | Details |
A08022 | 32278395 | Anal Chim Acta | Differentiation between stages of non-alcoholic fatty liver diseases using surface-enhanced Raman spectroscopy. | 2020 | Details |
A08023 | 32278041 | Pharmacol Res | The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials. | 2020 | Details |
A08025 | 32278004 | J Hepatol | A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. | 2020 | Details |
A08026 | 32277923 | Mol Metab | Functional changes of the liver in the absence of growth hormone (GH) action - Proteomic and metabolomic insights from a GH receptor deficient pig model. | 2020 | Details |
A08028 | 32277591 | Am J Transplant | Fatal outcome in a liver transplant recipient with COVID-19. | 2020 | Details |
A08030 | 32275982 | J Hepatol | Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis. | 2020 | Details |
A08032 | 32275114 | FASEB J | Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis. | 2020 | Details |
A08033 | 32274915 | Minerva Pediatr | Metabolic syndrome in children. | 2020 | Details |
A08034 | 32274348 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations. | 2019 | Details |
A08035 | 32274342 | J Clin Transl Hepatol | COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. | 2020 | Details |
A08036 | 32273892 | Int J Endocrinol | Association between Serum Uric Acid to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Lean Chinese Adults. | 2020 | Details |
A08038 | 32272865 | Adipocyte | MiR-455 targeting SOCS3 improve liver lipid disorders in diabetic mice. | 2020 | Details |
A08041 | 32272794 | Animals (Basel) | Identification of Crucial Genetic Factors, Such as PPARγ, that Regulate the Pathogenesis of Fatty Liver Disease in Dairy Cows Is Imperative for the Sustainable Development of Dairy Industry. | 2020 | Details |
A08042 | 32272251 | Clin Gastroenterol Hepatol | Diagnostic Performance of Vibration-Controlled Transient Elastography in Liver Transplant Recipients. | 2020 | Details |
A08043 | 32271954 | Acta Paediatr | Survey on screening for paediatric non-alcoholic fatty liver disease in clinical practice in Dutch hospitals. | 2020 | Details |
A08044 | 32271385 | J Clin Endocrinol Metab | Plasma BCAA Changes in Patients With NAFLD Are Sex Dependent. | 2020 | Details |
A08045 | 32270862 | Clin Infect Dis | Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease. | 2021 | Details |
A08046 | 32270583 | J Diabetes Investig | Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population. | 2020 | Details |
A08048 | 32268517 | J Clin Med | Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience. | 2020 | Details |
A08049 | 32268264 | Nutrition | Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH. | 2020 | Details |
A08050 | 32268115 | Cell Metab | TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation. | 2020 | Details |
A08051 | 32268108 | Cell Metab | On the Front Line: Obesity and NAFLD. | 2020 | Details |
A08052 | 32268002 | Diabetes Metab Res Rev | Association of bedtime with the risk of non-alcoholic fatty liver disease among middle-aged and elderly Chinese adults with pre-diabetes and diabetes. | 2020 | Details |
A08053 | 32267638 | Ned Tijdschr Geneeskd | [Non-alcoholic fatty liver disease; a full-bodied epidemic]. | 2020 | Details |
A08054 | 32267559 | J Gastroenterol Hepatol | Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time? | 2020 | Details |
A08055 | 32267269 | Food Funct | A lupine (Lupinus angustifolious L.) peptide prevents non-alcoholic fatty liver disease in high-fat-diet-induced obese mice. | 2020 | Details |
A08056 | 32267017 | J Clin Lab Anal | Revision of serum ALT upper limits of normal facilitates assessment of mild liver injury in obese children with non-alcoholic fatty liver disease. | 2020 | Details |
A08057 | 32266697 | Obes Surg | Sleeve Gastroplasty Combined with the NLRP3 Inflammasome Inhibitor CY-09 Reduces Body Weight, Improves Insulin Resistance and Alleviates Hepatic Steatosis in Mouse Model. | 2020 | Details |
A08059 | 32265720 | Front Pharmacol | The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism. | 2020 | Details |
A08061 | 32264657 | Korean J Intern Med | Association between high fatty liver index and development of colorectal cancer: a nationwide cohort study with 21,592,374 Korean. | 2020 | Details |
A08062 | 32259637 | Mol Cell Endocrinol | Anti-steatotic linagliptin pleiotropic effects encompasses suppression of de novo lipogenesis and ER stress in high-fat-fed mice. | 2020 | Details |
A08063 | 32259482 | Cell Metab | Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis. | 2020 | Details |
A08064 | 32258947 | Hepatol Commun | Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics. | 2020 | Details |
A08065 | 32258945 | Hepatol Commun | Bile Acid Diarrhea and NAFLD: Shared Pathways for Distinct Phenotypes. | 2020 | Details |
A08066 | 32258944 | Hepatol Commun | Pathogenesis of Nonalcoholic Steatohepatitis: An Overview. | 2020 | Details |
A08067 | 32258535 | Transl Gastroenterol Hepatol | Non-invasive diagnosis: non-alcoholic fatty liver disease and alcoholic liver disease. | 2020 | Details |
A08068 | 32258528 | Transl Gastroenterol Hepatol | Nonalcoholic steatohepatitis recurrence after liver transplant. | 2020 | Details |
A08069 | 32258523 | Transl Gastroenterol Hepatol | Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis. | 2020 | Details |
A08070 | 32258522 | Transl Gastroenterol Hepatol | Peri-transplant renal dysfunction in patients with non-alcoholic steatohepatitis undergoing liver transplantation. | 2020 | Details |
A08071 | 32258520 | Transl Gastroenterol Hepatol | Epidemiology of non-alcoholic and alcoholic fatty liver diseases. | 2020 | Details |
A08072 | 32258441 | Biochem Biophys Rep | Differentially expressed mRNAs and lncRNAs shared between activated human hepatic stellate cells and nash fibrosis. | 2020 | Details |
A08073 | 32258142 | Biomed Res Int | Aspirin Improves Nonalcoholic Fatty Liver Disease and Atherosclerosis through Regulation of the PPARδ-AMPK-PGC-1α Pathway in Dyslipidemic Conditions. | 2020 | Details |
A08074 | 32257903 | Lab Anim Res | Comparative study of liver injury induced by high-fat methionine- and choline-deficient diet in ICR mice originating from three different sources. | 2019 | Details |
A08075 | 32257815 | Mol Genet Metab Rep | Mtrr hypomorphic mutation alters liver morphology, metabolism and fuel storage in mice. | 2020 | Details |
A08076 | 32256659 | Evid Based Complement Alternat Med | Protective Effect of a Mixture of Astragalus membranaceus and Lithospermum erythrorhizon Extract against Hepatic Steatosis in High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Mice. | 2020 | Details |
A08077 | 32256346 | Front Pharmacol | Hepatoprotective Effect of Cranberry Nutraceutical Extract in Non-alcoholic Fatty Liver Model in Rats: Impact on Insulin Resistance and Nrf-2 Expression. | 2020 | Details |
A08078 | 32256270 | EXCLI J | Short term effects of coffee components consumption on gut microbiota in patients with non-alcoholic fatty liver and diabetes: A pilot randomized placebo-controlled, clinical trial. | 2020 | Details |
A08079 | 32256016 | World J Gastroenterol | Importance of genetic polymorphisms in liver transplantation outcomes. | 2020 | Details |
A08081 | 32255515 | Lipids | Lipid Profiles of Five Essential Phospholipid Preparations for the Treatment of Nonalcoholic Fatty Liver Disease: A Comparative Study. | 2020 | Details |
A08083 | 32253813 | J Cell Mol Med | Enhanced liver but not muscle OXPHOS in diabetes and reduced glucose output by complex I inhibition. | 2020 | Details |
A08084 | 32253274 | J Am Soc Nephrol | Fructose Production and Metabolism in the Kidney. | 2020 | Details |
A08085 | 32253259 | Gut | LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover. | 2020 | Details |
A08086 | 32252641 | BMC Gastroenterol | Magnetic resonance elastography in staging liver fibrosis in non-alcoholic fatty liver disease: a pooled analysis of the diagnostic accuracy. | 2020 | Details |
A08087 | 32252638 | BMC Gastroenterol | Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study. | 2020 | Details |
A08088 | 32252024 | J Endocrinol | miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway. | 2020 | Details |
A08089 | 32251945 | Bioorg Chem | Discovery of novel dual PPARα/δ agonists based on benzimidazole scaffold for the treatment of non-alcoholic fatty liver disease. | 2020 | Details |
A08090 | 32251018 | Clin Transl Gastroenterol | Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
A08091 | 32250592 | Anal Chem | Double Derivatization Strategy for High-Sensitivity and High-Coverage Localization of Double Bonds in Free Fatty Acids by Mass Spectrometry. | 2020 | Details |
A08092 | 32250344 | J Clin Invest | Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice. | 2020 | Details |
A08093 | 32249283 | J Infect Dis | Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection. | 2020 | Details |
A08094 | 32249131 | Semergen | [Descriptive study of hepatic steatosis and associated morbidity in Primary Care. (ESTEATOAP Study)]. | 2020 | Details |
A08095 | 32247823 | J Hepatol | Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis. | 2020 | Details |
A08096 | 32246926 | Exp Mol Pathol | Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in SHRSP5/Dmcr rat model. | 2020 | Details |